Webinar: Narrowing the Focus: Optimizing Antibiotic Spectrum through Diagnostics and Stewardship

Click Here to Register

Overview

This expert-led webinar addresses the ongoing challenge of unnecessary broad-spectrum antibiotic use and its associated risks. Experts will explore strategies for optimizing prescribing in sepsis care, pediatrics, and beyond. This webinar will highlight opportunities to inform decision-making based on diagnostics, patient risk factors, and local epidemiology.

Speakers

Tristan T. Timbrook, PharmD, MPH, MBA, Adjunct Assistant Professor, University of Utah College of Pharmacy; Infectious Diseases Pharmacist, Barnes-Jewish Hospital
Chanu Rhee, MD, MPH: Director, Center for Sepsis Epidemiology and Prevention Studies (SEPSIS), Harvard Pilgrim Health Care Institute
Jeffrey S. Gerber, MD, PhD: Professor, Pediatrics and Epidemiology, University of Pennsylvania School of Medicine
Moderator: Marnie Peterson, PharmD, PhD: Outreach Coordinator for the Antimicrobial Stewardship Project at CIDRAP will serve as moderator

Learning Objectives

After attending this activity, learners will be able to:

Identify the risks associated with inappropriate broad-spectrum antibiotic prescribing.
Discuss the role of rapid diagnostics and timely communication in guiding targeted antibiotic therapy.
Apply evidence-based strategies to balance prescribing urgency and stewardship in different clinical scenarios.

Continuing Education

Learners can claim Continuing Education credit via this activity evaluation within 30 days of activity completion. MAD-ID will send credits for pharmacy learners to CE Monitor within four weeks of submission. Learners claiming AMA PRA Category 1 Credits™ can expect to receive PDF certificates via email in a similar timeframe. Please reach out to info@mad-id.org with any questions or specific requests.

The types of CE available for this webinar include:

Continuing Pharmacy Education: MAD-ID is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This enduring activity has been approved for a maximum of 1.0 contact hours.
Continuing Medical Education: This enduring activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). MAD-ID is accredited by the ACCME to provide continuing medical education (CME) for physicians. MAD-ID designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioner and Registered Nurse Education: For recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center also accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.